CLVT stock touches 52-week low at $3.99 amid market challenges

Published 12/03/2025, 15:14
CLVT stock touches 52-week low at $3.99 amid market challenges

In a turbulent market environment, Clarivate Plc (CLVT) stock has reached a 52-week low, dipping to $3.99. According to InvestingPro data, the company’s technical indicators suggest oversold conditions, with a market capitalization of $2.77 billion and impressive gross profit margins of 66%. The company, known for its analytics and insights in global research, has faced significant headwinds over the past year, reflected in a stark 1-year change with a decline of 43.28%. Investors have shown concern as the stock struggles to regain momentum amidst broader economic pressures and sector-specific challenges. The current price level marks a critical juncture for Clarivate, as stakeholders closely monitor the company’s performance and strategic initiatives for signs of a turnaround. InvestingPro analysis suggests the stock is currently undervalued, with analyst targets ranging from $4 to $8 per share. Discover 14 additional exclusive ProTips and comprehensive technical analysis tools with an InvestingPro subscription.

In other recent news, Clarivate PLC reported its fourth-quarter results for 2024, revealing a slight earnings beat with an adjusted diluted EPS of $0.21, surpassing the forecasted $0.20. However, the company’s revenue fell short, recording $663 million against a projected $670.96 million. For the full year, Clarivate’s revenue reached $2.56 billion, with an adjusted diluted EPS of $0.73. Looking ahead, the company forecasts 2025 revenue at approximately $2.34 billion, with a diluted adjusted EPS range of $0.60 to $0.70. In governance-related news, Clarivate announced that board member Michael J. Angelakis plans to retire in May 2025. The company has not yet announced any candidates for Angelakis’s position on the Board. Additionally, Clarivate is undergoing a strategic shift towards subscription-based models and innovative product development. These recent developments are part of Clarivate’s ongoing efforts to optimize operational structures and enhance recurring revenue.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.